EARLY IRON OVERLOAD IN BETA-THALASSEMIA MAJOR - WHEN TO START CHELATION-THERAPY

被引：21

作者：

FARGION, S

TADDEI, MT

GABUTTI, V

PIGA, A

DIPALMA, A

CAPRA, L

FONTANELLI, G

AVANZINI, A

机构：

[1] UNIV MILAN,DEPT CLIN MED 3,I-20122 MILAN,ITALY

[2] UNIV TURIN,DEPT CLIN PAEDIAT,I-10126 TURIN,ITALY

[3] OSPED S ANNA,FERRARA,ITALY

[4] CATTEDRA PUERICULTURA,MILAN,ITALY

来源：

ARCHIVES OF DISEASE IN CHILDHOOD | 1982年 / 57卷 / 12期

关键词：

D O I：

10.1136/adc.57.12.929

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：929 / 933

页数：5

共 15 条

[1] LONG-TERM CHELATION THERAPY IN THALASSEMIA MAJOR - EFFECT ON LIVER IRON CONCENTRATION, LIVER HISTOLOGY, AND CLINICAL PROGRESS [J].

BARRY, M ;

FLYNN, DM ;

LETSKY, EA ;

RISDON, RA .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 2 (5909) :16-20

[2] A NON-TRANSFERRIN-BOUND SERUM IRON IN IDIOPATHIC HEMOCHROMATOSIS [J].

BATEY, RG ;

FONG, PLC ;

SHAMIR, S ;

SHERLOCK, S .

DIGESTIVE DISEASES AND SCIENCES, 1980, 25 (05) :340-346

[3] NONSPECIFIC SERUM IRON IN THALASSEMIA - ABNORMAL SERUM IRON FRACTION OF POTENTIAL TOXICITY [J].

HERSHKO, C ;

GRAHAM, G ;

BATES, GW ;

RACHMILEWITZ, EA .

BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (02) :255-263

[4]

HOFFBRAND AV, 1979, LANCET, V1, P947

[5]

HUISMAN THJ, 1975, J LAB CLIN MED, V86, P700

[6]

Letsky E A, 1976, Birth Defects Orig Artic Ser, V12, P31

[7] SURVIVAL AND DESFERRIOXAMINE IN THALASSEMIA MAJOR [J].

MODELL, B ;

LETSKY, EA ;

FLYNN, DM ;

PETO, R ;

WEATHERALL, DJ .

BRITISH MEDICAL JOURNAL, 1982, 284 (6322) :1081-1084

[8] LONG-TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA [J].

MODELL, CB ;

BECK, J .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 232 (MAY24) :201-210

[9]

PIPPARD MJ, 1978, LANCET, V1, P1178

[10] CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF DEFEROXAMINE IN PATIENTS WITH IRON OVERLOAD [J].

PROPPER, RD ;

COOPER, B ;

RUFO, RR ;

NIENHUIS, AW ;

ANDERSON, WF ;

BUNN, HF ;

ROSENTHAL, A ;

NATHAN, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (08) :418-423

← 1 2 →